Are you a journalist?

Get to know ALK

If you have any queries please feel free to contact Media Relations at ALK headquarters or one of our global offices.

The press releases in this press room contains information that is of general news value for the press, and available for journalists or media with a view to journalistic assessment and preparation before publication.

News

  • Post date
    02/21/2018
    New medicine for house dust mite allergic rhinitis and allergic asthma now available in France
  • Post date
    02/16/2018
    ALK’s partner, Torii, gains paediatric approval for the house dust mite SLIT-tablet in Japan
  • Post date
    02/13/2018
    Annual General Meeting in ALK-Abelló A/S on 12 March 2018
  • Post date
    01/30/2018
    Release date of annual report 2017 and audio cast
  • Post date
    01/11/2018
    New Treatment for House Dust Mite (HDM) – Induced Allergic Rhinitis Now Available in US
  • Post date
    12/20/2017
    ALK – Financial calendar for the 2018 financial year
  • Post date
    12/11/2017
    REGISTRATION OF CAPITAL INCREASE OF DKK 92,076 AA SHARES AND DKK 920,760 B SHARES BY THE ISSUE OF NEW SHARES COMPLETED
  • Post date
    12/07/2017
    PRICING AND FURTHER DETAILS ON THE OFFERING OF NEW SHARES IN ALK-ABELLÓ A/S
  • Post date
    12/06/2017
    ALK-ABELLÓ A/S TO ISSUE UP TO 92,076 AA SHARES AND UP TO 920,760 B SHARES IN A PRIVATE PLACEMENT

Media Relations

Per Plotnikof
Vice President,
Corporate Communications,
Investor Relations and Strategic Planning
Phone: +45 22612525
Email: PPIDK@alk.net

Jeppe Ilkjær
Media Relations Manager
Corporate Communications
Phone: +45 30502014
Email: Jeppe.Ilkjaer@alk.net

Journalists are always welcome to contact ALK’s Media Relations team.
Søren Niegel, EVP Commercial Operations and Product Supply
Henrik Jacobi, EVP Research and Development
Søren Jelert, CFO
Production facilities, Hørsholm
Production facilities, Hørsholm
Production facilities, Hørsholm
ALK HQ, Hørsholm
Last updated: 2018.01.12